Sebela Pharmaceuticals Inc.

Overview

This specialty pharmaceutical company, headquartered in Roswell, Georgia, has focused since 2013 on the commercialization and development of prescription products in Gastroenterology, Women's Health, and Dermatology. Their dedication centers on improving patient lives through innovative pharmaceutical solutions, leveraging research and development to provide market-leading therapies.

With expansions in Gastroenterology—particularly after acquiring Braintree Laboratories in 2018—Sebela enhances offerings in colonoscopy preparation products. Women's Health initiatives include tailored options such as a hormone-free, low-dose copper intrauterine device currently in Phase 3 trials. The Dermatology division deploys an internal sales force to market under-represented products and broaden its portfolio.

Basic Information

Contact Details

• Phone: +1 844-732-3521
• Website: sebelapharma.com
• LinkedIn: linkedin.com/company/sebela-pharmaceuticals-llc

Key Focus Areas & Initiatives

• Gastroenterology
• Women's Health
• Dermatology
• Pharmaceutical manufacturing
• Research and development
• Colonoscopy prep products
• NDA filings
• Clinical trials
• IUD innovations
• Biotech
• B2B services
• Medical devices
• Pipeline development
• Oncology
• Pharmaceutical development
• Reflux disease therapies
• Congenital therapies
• Patient care
• Phase 3 programs
• Healthcare
• GERD treatments
• Cancer screening products
• Contraceptive products
• Manufacturing
• Medical research
• Health care
• Health, wellness & fitness
• Hospital & health care
• Mechanical or industrial engineering

Technologies Used

• ASP.NET
• Amazon AWS
• Bootstrap Framework
• Google Tag Manager
• Microsoft Office 365
• Microsoft-IIS
• Mimecast
• Mobile Friendly
• Oracle Cloud
• Outlook
• Remote
• Slack

Affiliated Organizations & Regional Branches